Sarcopenia Index Predicts Short-Term Prognosis of Head and Neck Squamous Cell Carcinoma

= 0.006). There was no significant difference in OS between the low-and high-CTMSA and -BIA-MM groups. The SI, which only requires a blood sample, is a useful marker of muscle mass that correlates with short-term prognosis in patients with HNC.